Precision Biosciences (DTIL) Times Interest Earned (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Times Interest Earned came in at -$18.19 in Q1 2026, up 60.19% year-on-year from -$11.35 in Q1 2025, and down 229.11% on a QoQ basis from $14.09 in Q4 2025.
Precision Biosciences (DTIL) Times Interest Earned (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Times Interest Earned data on file, last reported at -$18.19 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 60.19% year-over-year to -$18.19 in Q1 2026; TTM through Mar 2026 was -$16.51, a 14.06% increase from a year earlier, with the FY2025 full-year figure at -$0.36, down 87.79% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$18.19, down from $14.09 in the prior quarter.
- Over the last five years, Times Interest Earned for DTIL reached as high as $14.09 in Q4 2025 and fell as low as -$49.89 in Q4 2024.
- Historically, Times Interest Earned has averaged -$14.9 across 5 years, with a median of -$7.29 in 2024.
- Across the five-year window, Times Interest Earned tumbled 2453.64% in 2022 and surged 573.76% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$6.57 in 2022, then sank by 206.5% to -$20.15 in 2023, then plunged by 147.61% to -$49.89 in 2024, then soared by 128.23% to $14.09 in 2025, then slumped by 229.11% to -$18.19 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$18.19 in Q1 2026, $14.09 in Q4 2025, and -$2.58 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -157.58 |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 3.88 |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | -18.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.19 |
| Dec 31, 2025 | 14.09 |
| Sep 30, 2025 | -2.58 |
| Jun 30, 2025 | -15.54 |
| Mar 31, 2025 | -45.69 |
| Dec 31, 2024 | -49.89 |
| Sep 30, 2024 | -2.14 |
| Jun 30, 2024 | 2.32 |
| Mar 31, 2024 | -7.29 |
| Dec 31, 2023 | -20.15 |
| Sep 30, 2023 | -41.63 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -23.35 |
| Dec 31, 2022 | -6.57 |
| Sep 30, 2022 | -27.74 |
| Jun 30, 2022 | -4.55 |
| Mar 31, 2022 | -3.87 |
| Dec 31, 2021 | -320.04 |
| Sep 30, 2021 | -1.09 |
| Jun 30, 2021 | 10.13 |